Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic

Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic

Abstract Background Myasthenia gravis (MG) is a rare autoimmune disorder with significant clinical implications, including life-threatening myasthenic crises and exacerbations. Understanding real-world treatment patterns, especially associated direct medical costs, is essential for the effective man...

Description complète

Détails bibliographiques
Auteurs principaux: Gleb Donin, Karla Mothejlová, Magda Horáková, Stanislav Vohanka
Format: Article
Langue:English
Publié: BMC 2024-12-01
Collection:Orphanet Journal of Rare Diseases
Sujets:
Myasthenia gravis
Treatment patterns
Direct healthcare costs
Accès en ligne:https://doi.org/10.1186/s13023-024-03504-3

Internet

https://doi.org/10.1186/s13023-024-03504-3

Documents similaires